Literature DB >> 4355703

Neurogenic factors in human hypertension: mechanism or myth?

V DeQuattro, Y Miura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4355703     DOI: 10.1016/0002-9343(73)90136-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

2.  Baroreflex sensitivity and cardiopulmonary blood volume in normotensive and hypertensive patients.

Authors:  A C Simon; M E Safar; Y A Weiss; G M London; P L Milliez
Journal:  Br Heart J       Date:  1977-07

3.  [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].

Authors:  P Weidmann; C Beretta-Piccoli; W Ziegler; D Hirsch; R D de Châtel; F C Reubi
Journal:  Klin Wochenschr       Date:  1976-08-15

4.  The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension.

Authors:  M J Davey
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

5.  Adrenergic regulation of blood pressure in chronic renal failure.

Authors:  J J Lilley; J Golden; R A Stone
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

6.  Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.

Authors:  K O Stumpe; R Kolloch; W Gramann; H Vetter; C Ressel; M Higuchi; F Krück
Journal:  Klin Wochenschr       Date:  1976-08-15

7.  Metabolic and hormonal studies in patients with essential hypertension.

Authors:  W Januszewicz; M Ciswicka-Sznajderman; B Wocial; M Sznajderman; H Ignatowska-Switalska; H Berent; Z Zukowska-Grojec; T Feltynowski
Journal:  Br Heart J       Date:  1977-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.